Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer (2024) Klümper N, Vera-Badillo FE, Eckstein M, Hadaschik B, Grünwald V Journal article Reply to Jon Griffin. TIME for a Change? Multimarker Assessment of the Tumour Immune Microenvironment and Metastatic Site Biopsy to Improve Immunotherapy Response Prediction in Muscle-invasive Bladder Cancer. Eur Urol. 2023;43:143–4 (2023) Klümper N, Hölzel M, Eckstein M Journal article Nivolumab Switch Maintenance Therapy After Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma: A Randomized Clinical Trial by the Interdisciplinary Working Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass) (2023) Grünwald V, Ivanyi P, Zschäbitz S, Wirth M, Staib P, Schostak M, Dargatz P, et al. Journal article Reply to Mattias Höglund's Letter to the Editor re: Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020 (2023) Klümper N, Cox A, Eckstein M Journal article Re: First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma: Navigating Metastatic Urothelial Cancer with Nectin-4 PET/CT (2023) Klümper N, Eckstein M, Hölzel M, Herrmann K, Hadaschik B, Grünwald V Journal article Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution (2023) Cox A, Klümper N, Stein J, Sikic D, Breyer J, Bolenz C, Roghmann F, et al. Journal article Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82. (2023) Rubin MA, Amin MB, Compérat E, Gill A, Hartmann A, Menon S, Raspollini M, et al. Journal article European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines (2023) Alfred Witjes J, Max Bruins H, Carrión A, Cathomas R, Compérat E, Efstathiou JA, Fietkau R, et al. Journal article, Review article Subtype specific expression of radioligand targets in the prospective Real World clinico-pathological register trial BRIDGister (2022) Wirtz R, Friedersdorff F, Barski D, Otto T, Bug R, Veltrup E, Kilic E, et al. Conference contribution Gender differences in Urologic training - results of the second GeSRU (Germany Society of Residents in Urology) training survey (2022) Siech C, Arnold H, Mattigk A, Bellut L, Koenig J, Kluth LA Conference contribution